Time to sell your Rapid Micro Biosystems stock?
Roth Capital Partners analyst Max Masucci downgraded Rapid Micro Biosystems (Rapid Micro Biosystems I Stock Quote, Chart, News, Analysts, Financials TSXV:RPID) to “Neutral” from “Buy” and lowered his target to US$0.75 from $3.00 following the announcement of a definitive agreement for the company to be acquired by Germany’s Merck KGaA.
In a Nov. 16 report, Masucci said the all-cash offer of $0.75 per share reflects the strategic value of Rapid Micro’s automated microbial quality-control technology and its existing relationship with Merck’s MilliporeSigma business.
“The acquisition builds on the company’s existing partnership with MilliporeSigma, which spans Growth Direct distribution, potential consumable sourcing benefits, and joint development,” Masucci said.
The transaction is expected to close in December 2026, subject to completion of the tender offer, satisfaction of the minimum tender condition and other customary closing requirements. Using approximately 55 million fully diluted shares, Masucci estimated the transaction’s equity value at US$41-million and enterprise value at approximately US$54-million, representing 1.2 times his fiscal 2027 revenue forecast of US$45.6-million.
Rapid Micro’s Growth Direct platform automates microbial testing for manufacturers of vaccines, biologics, cell and gene therapies and other sterile pharmaceutical products. The system combines automated laboratory equipment, consumables and software to replace manual testing procedures.
Masucci said MilliporeSigma’s international distribution network could help accelerate adoption of the technology while reducing the cost of expanding sales.
“The strategic fit is consistent with our initiation thesis: MilliporeSigma’s global commercial reach could expand Growth Direct adoption across customers, sites, and geographies without requiring proportional investment in RPID’s standalone sales infrastructure,” he said. “Beyond distribution, we see potential for lower-cost consumable sourcing and joint software and product development to drive GM expansion for Growth Direct and incorporate the system into a broader automated quality-control workflow.”
The acquisition announcement followed Rapid Micro’s third-quarter results, which showed revenue increasing 22% year-over-year to US$9.5-million, in line with Masucci’s forecast. Gross margin reached 25.2%, exceeding his 21.2% estimate, while the company placed seven Growth Direct systems, matching expectations. It also completed 12 customer validations, ahead of his forecast of 10. The Adjusted EBITDA loss narrowed to US$7.9-million, slightly better than Masucci’s expected loss of US$8.1-million. The company reported a loss of US$0.23 per share, compared with his forecast loss of US$0.21.
Rapid Micro withdrew its fiscal 2026 guidance following the acquisition announcement.
Masucci’s revised target matches the proposed purchase price, with the transaction’s completion now the principal consideration for shareholders.
-30-
Rod Weatherbie
Writer
Rod Weatherbie is a journalist based in Prince Edward Island. Since 2004, he has written extensively about the Canadian property and casualty insurance landscape. He was also a founder and contributing editor for a Toronto-based arts website and a PEI-based food magazine. His fiction and poetry have been featured in The Fiddlehead, The Antigonish Review, and Juniper.